Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"Anti-TNF agents"”.
-
Μελέτη της λοίμωξης από τον ιό της ηπατίτιδας β σε ασθενείς με ρευματικές παθήσεις που υποβάλλονται σε ανοσοκατασταλτική αγωγή
… prospective study was to examine the safety of anti-tumour necrosis factor (TNF) therapy in patients with rheumatic disease and hepatitis B virus (HBV) infection. Methods 14 patients with chronic HBV infection, 19 HBV-vaccinated patients and 19 patients with resolved HBV infection were included …
-
Redefining the Management of Perianal Fistulising Crohn’s Disease: From Streamlined Care to Targeted Therapeutics
… advances in biologic treatment, including anti-tumour necrosis factor (anti-TNF) agents and newer targeted therapies, rates of sustained fistula healing remain modest. Furthermore, existing clinical classification systems are largely anatomy-based and may not adequately reflect the …
-
Κλινικά, επιδημιολογικά και ανοσογενετικά δεδομένα της αρτηριίτιδας Takayasu στην Ελλάδα
… The sera of 24 patients were screened for antiendothelial-cell antibodies but none was found positive. Twenty-two patients were also screened for HLA and the results were compared to the general Greek population. Thirty eight percent of patients expressed HLA B52 in comparison to 2.4% of …
-
Μελέτη της λοίμωξης από το μυκοβακτηρίδιο της φυματίωσης σε ασθενείς με αυτοάνοσες ρευματικές παθήσεις
… (TB) screening test conversion during anti-tumour necrosis factor (TNF) therapy in rheumatic patients with negative baseline screening.Methods: Prospective study of rheumatic patients with negative baseline TB screening (tuberculin skin test (TST): <5 mm, and negative T-SPOT.TB, …
-
An exploration of variation in the management of Crohn’s anal fistula
… 27 trials of pharmacological therapies. Anti-tumour necrosis factors (TNF) drugs were associated with induction (RR, 2.01; 95% CI, 1.36-2.97) and maintenance of response (RR 1.94 CI 1.25-3.02). Review of the surgical literature identified 63 studies, of which three were …
-
Functional characterisation of a multiple sclerosis-associated genetic variant
… encoding the principle receptor for the cytokine TNF (TNFR1), TNFRSF1A, has been replicated several times since its initial identification by De Jager et al., 2009. This study demonstrates that the MS risk-associated G allele of this SNP, rs1800693, results in an alternative splicing event in …
-
Blocking Brain Tumor Necrosis Factor to Alleviate Persistent Inflammatory Pain
Research on tumor necrosis factor-alpha (TNF) has well established its role in pain. Following an injury, TNF is secreted by inflammatory cells, as well as other cell types. TNF sensitizes neurons via increasing glutamate causing them to become hyper-excitable, which is involved in the pathogenesis …
-
Economic evaluations in the context of treatment recommendations in spondyloarthritis : analyses from the DESIR cohort
… regression models. This study showed that anti-TNF agents were the greatest cost driver in DESIR and generated the cost outcomes necessary to perform economic evaluations using DESIR data. The objective of study 2 was to collaborate with rheumatologists to develop measurable definitions of …
-
Εκτίμηση της μεταβολής της ελαστικότητας των μεγάλων αρτηριών μετά από χορήγηση αντι- TNF παραγόντων σε ασθενείς με ρευματοειδή αρθρίτιδα: συγκριτική μελέτη
… whether there is an effect of treatment with the TNF antagonist adalimumab on aortic stiffness in RA patients and whether that effect is independent of the response to treatment. Furthermore, we examined whether there is a differential effect on aortic stiffness among patients treated with a …
-
Φαρμακογενωμική ανάλυση ασθενών με ιδιοπαθή φλεγμονώδη νόσο του εντέρου (ΙΦΝΕ) και συσχέτιση με ανταπόκριση στους αντι-TNF παράγοντες
… colitis and Crohn's disease. The pharmaceutical agents that are used for the treatment of IBD include aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and in recent years, biological therapies which include the anti-TNF agents. However, because of the great heterogeneity in …
-
The human mucosal and circulating immunome in inflammatory bowel disease as novel tools for patient stratification and response to advanced therapies
… adaptive immune responses. Cytokines such as TNF-α, IL-1β, IL-6, IL-12, and IL-23 drive inflammatory cascades, whereas regulatory mediators including IL-10 and TGF-β attempt to restore immune tolerance. This coexistence of pro-inflammatory and regulatory pathways underlies disease variability …
-
Progression of structural damage in the sacroiliac joints in patients with early axial spondyloarthritis during long-term antitumor necrosis factor treatment
… identified mostly in patients not treated with TNF inhibitors. To date, it is not clear whether these predictors also work in patients treated with anti- TNF agents and whether anti-TNF therapy is able to retard such a progression. Objective: To assess the radiographic progression in the …
-
Μελέτη των αλλοιώσεων της ψωριασικής ονυχίας και συσχέτιση της ειδικής κλίμακας βαρύτητας με δείκτες φλεγμονής
… disease severity and quality of life impairment. TNF-α, IL-12/23 p40, and IL-17 play an important role in the pathogenesis of psoriasis. Our initial aim was to study the presence of nail involvement in patients with psoriasis, its characteristics and its possible correlations. Psoriatic patients, …
-
The Effectiveness of Leflunomide Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis:a systematic review
… with an unidentified cause, and has a substantial societal effect in terms of cost, disability, and lost productivity. Much emphasis has been geared towards investigating the pathogenesis of RA, and to identify aetiologic markers. Greater insight into the cellular and molecular systems of RA …
-
Epidemiology and natural history of paediatric-onset inflammatory bowel disease in Scotland
… to manage symptoms in this patient cohort. Anti-TNF alpha antagonists have been used to treat PIBD and shown in large single centre studies to be effective at the induction and maintenance of remission, however, these studies may not reflect the general PIBD patients’ clinicians treat daily …
-
Long term response and safety of biologic therapies in Greek patients with rheumatic diseases
… and societal burden. The advent of biologic agents, such as tumor necrosis factor inhibitors (TNFis), has dramatically transformed the management of these diseases. TNFis were proven effective in randomized controlled studies (RCTs) of both RA and SpA patients. However, questions that …
-
Μια μελέτη ανάλυσης συσχετισμού ολόκληρου του γονιδιώματος για τον προσδιορισμό μονηρών νουκλεοτιδικών πολυμορφισμών που προδιαθέτουν στην εκδήλωση διαπυητικής ιδρωταδενίτιδας
… were divided into visits under treatment with agents blocking tumor necrosis factor (anti-TNFs) or other therapies. The cost of exacerbations was calculated. The effectiveness of anti-TNFs was calculated by the containment of exacerbations. The primary endpoint for this part of the study was …
-
Κλινική και ανοσολογική μελέτη της επίδρασης των βιολογικών παραγόντων στη νεανική ιδιοπαθή αρθρίτιδα
… the long-term safety and efficacy of biologic agents in patients with Juvenile Idiopathic Arthritis (JIA) and b) to investigate the impact of anti TNFs on Τ cell activation and proliferation response. The safety and efficacy of infliximab etanercept adalimumab and anakinra were assessed in 69 …
-
Μελέτη της θεραπείας με ανοσοτροποιητικά φάρμακα και βιολογικούς παράγοντες σε ασθενείς με ιδιοπαθή φλεγμονώδη νόσο των εντέρων
… between serum infliximab trough levels (TLs), antibodies-to-infliximab (ATI) and therapeutic outcomes in patients with ulcerative colitis (UC) and Crohn’s disease (CD) within a Greek population. The relationship between infliximab-related infusion reactions (IRs) and the presence of ATI was …
-
Μελέτη του πνευμονικού παρεγχύματος με υπολογιστική τομογραφία θώρακος υψηλής ευκρίνειας σε ασθενείς με ρευματοειδή αρθρίτιδα πριν και μετά τη θεραπεία με anti-TNF παράγοντες
… at baseline and after one-year οf treatment with anti-TNF agents AbstractIntroduction to Rheumatoid Arthritis Rheumatoid arthritis (RA) is a chronic, autoimmune systemic inflammatory disease. RA represents the most frequent inflammatory disease, affecting approximately 0.5-2% of the worldwide …